Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C10H14BrNO2.BrH |
| Molecular Weight | 341.04 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Br.COC1=CC(CCN)=C(OC)C=C1Br
InChI
InChIKey=WGWOFNYIBCKZMV-UHFFFAOYSA-N
InChI=1S/C10H14BrNO2.BrH/c1-13-9-6-8(11)10(14-2)5-7(9)3-4-12;/h5-6H,3-4,12H2,1-2H3;1H
| Molecular Formula | BrH |
| Molecular Weight | 80.912 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C10H14BrNO2 |
| Molecular Weight | 260.128 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL322 Sources: https://www.ncbi.nlm.nih.gov/pubmed/16970404 |
27.0 nM [EC50] |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Metabolism of designer drugs of abuse: an updated review. | 2010-06-01 |
|
| Cerebral vasculopathy after 4-bromo-2,5-dimethoxyphenethylamine ingestion. | 2010-05 |
|
| Liquid chromatography-atmospheric pressure ionization electrospray mass spectrometry determination of "hallucinogenic designer drugs" in urine of consumers. | 2008-06-09 |
|
| Disposition of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) and its metabolite 4-bromo-2-hydroxy-5-methoxyphenethylamine in rats after subcutaneous administration. | 2008-04-21 |
|
| Comparative potencies of 3,4-methylenedioxymethamphetamine (MDMA) analogues as inhibitors of [3H]noradrenaline and [3H]5-HT transport in mammalian cell lines. | 2007-12 |
|
| Studies on the toxicological detection of the designer drug 4-bromo-2,5-dimethoxy-beta-phenethylamine (2C-B) in rat urine using gas chromatography-mass spectrometry. | 2007-02-01 |
|
| 1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agonists. | 2006-09-21 |
|
| Optimization of the separation and on-line sample concentration of phenethylamine designer drugs with capillary electrophoresis-fluorescence detection. | 2006-01-06 |
|
| A study of the metabolism of methamphetamine and 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in isolated rat hepatocytes. | 2005-03-10 |
|
| Metabolic pathways of 4-bromo-2,5-dimethoxyphenethylamine (2C-B): analysis of phase I metabolism with hepatocytes of six species including human. | 2005-01-05 |
|
| Metabolism of the designer drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in mice, after acute administration. | 2004-11-25 |
|
| A general screening and confirmation approach to the analysis of designer tryptamines and phenethylamines in blood and urine using GC-EI-MS and HPLC-electrospray-MS. | 2004-09 |
|
| 4-Bromo-2,5-dimethoxyphenethylamine (2C-B) and structurally related phenylethylamines are potent 5-HT2A receptor antagonists in Xenopus laevis oocytes. | 2004-04 |
|
| Simultaneous determination of amphetamine derivatives in human urine after SPE extraction and HPLC-UV analysis. | 2004-03 |
|
| 4-Bromo-2,5-dimethoxyphenethylamine (2C-B): a review of the public domain literature. | 2003-03-14 |
|
| In vivo metabolism of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in the rat: identification of urinary metabolites. | 2002-03 |
|
| Automated headspace solid-phase microextraction and in-matrix derivatization for the determination of amphetamine-related drugs in human urine by gas chromatography-mass spectrometry. | 2002-01 |
|
| Fluorometric determination of DL-fenfluramine, DL-norfenfluramine and phentermine in plasma by achiral and chiral high-performance liquid chromatography. | 2001-11-05 |
|
| [A case of acute psychotic episode after a single dose of ecstasy]. | 2001-06-16 |
|
| WHO Expert Committee on Drug Dependence. Thirty-second report. | 2001 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 11:53:43 GMT 2025
by
admin
on
Wed Apr 02 11:53:43 GMT 2025
|
| Record UNII |
GE2MXV3PWY
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
GE2MXV3PWY
Created by
admin on Wed Apr 02 11:53:43 GMT 2025 , Edited by admin on Wed Apr 02 11:53:43 GMT 2025
|
PRIMARY | |||
|
163203510
Created by
admin on Wed Apr 02 11:53:43 GMT 2025 , Edited by admin on Wed Apr 02 11:53:43 GMT 2025
|
PRIMARY | |||
|
2001061-73-8
Created by
admin on Wed Apr 02 11:53:43 GMT 2025 , Edited by admin on Wed Apr 02 11:53:43 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|